The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study
Abstract Background Periodontal disease is a major health problem that results in tooth loss and thus affects oral health, which affects quality of life. In particular, schizophrenic patients are at higher risk for periodontal disease due to several factors, including the effect of antipsychotic med...
Main Authors: | Rania Shalaby, Ahmed Elmahdy, Christine Mikhail |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Oral Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12903-023-03404-1 |
Similar Items
-
Antipsychotic-induced Hyperprolactinemia
by: Suheyla Dogan Bulut, et al.
Published: (2015-06-01) -
Drug induced hyperprolactinemia
by: M. H. Wattegama, et al.
Published: (2017-10-01) -
New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01) -
Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
by: Wang Z, et al.
Published: (2023-04-01) -
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
by: Eiji Kirino
Published: (2017-11-01)